Publications by authors named "Jeremy Cetnar"

Claim this Profile
R
Radiologists' Perceptions of the 21st Century Cures Act.
Jessica H Porembka, Emily L Paton, Yin Xi, Ruth C Carlos, Sheena Bhalla, Jeremy P Cetnar

J Am Coll Radiol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Time toxicity in previously untreated metastatic or unresectable epidermal growth factor receptor-mutant non-small cell lung cancer: a clinical practice review.
Won Jin Jeon, Bowon Joung, Padma Sri Katikaneni, Akshit Chitkara, Neha Agrawal, Jeremy Cetnar

Transl Lung Cancer Res· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Landscape assessment of patient-reported outcome item coverage of tyrosine kinase inhibitor-associated adverse events.
Emily L Paton, Jeremy P Cetnar, Janet Freeman-Daily, Jill Feldman, Bellinda L King-Kallimanis

J Natl Cancer Inst· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SUPE_R Surveillance? PET/CT in Post-Treatment NSCLC and the Imperative of Proof Before Practice.
Rajat Thawani, Naga Praneeth Raja, Jeremy Cetnar

J Thorac Oncol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PrECOG PrE0807: A Phase 1b Feasibility Trial of Neoadjuvant Nivolumab Without and with Lirilumab in Patients with Muscle-invasive Bladder Cancer Ineligible for or Refusing Cisplatin-based Neoadjuvant Chemotherapy.
Petros Grivas, Vadim S Koshkin, Xiangying Chu, Suzanne Cole, Rohit K Jain, Jeremy P Cetnar

Eur Urol Oncol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Correction: Gemcitabine and cisplatin plus nivolumab as organ-sparing treatment for muscle-invasive bladder cancer: a phase 2 trial.
Matthew D Galsky, Siamak Daneshmand, Sudeh Izadmehr, Edgar Gonzalez-Kozlova, Kevin G Chan, Jeremy Paul Cetnar

Nat Med· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gemcitabine and cisplatin plus nivolumab as organ-sparing treatment for muscle-invasive bladder cancer: a phase 2 trial.
Matthew D Galsky, Siamak Daneshmand, Sudeh Izadmehr, Edgar Gonzalez-Kozlova, Kevin G Chan, Jeremy Paul Cetnar

Nat Med· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Rovalpituzumab Tesirine Compared With Topotecan as Second-Line Therapy in DLL3-High SCLC: Results From the Phase 3 TAHOE Study.
Fiona Blackhall, Kevin Jao, Laurent Greillier, Byoung Chul Cho, Konstantin Penkov, Jeremy Cetnar

J Thorac Oncol· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relevance of circulating hybrid cells as a non-invasive biomarker for myriad solid tumors.
Matthew S Dietz, Thomas L Sutton, Brett S Walker, Charles E Gast, Luai Zarour, Jeremy P Cetnar

Sci Rep· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized phase 2 trial of pembrolizumab versus pembrolizumab and acalabrutinib in patients with platinum-resistant metastatic urothelial cancer.
Tian Zhang, Michael R Harrison, Peter H O'Donnell, Ajjai S Alva, Noah M Hahn, Jeremy Cetnar

Cancer· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Timeline of Immune Checkpoint Inhibitor Approvals in Small Cell Lung Cancer.
Jennifer Gill, Jeremy Paul Cetnar, Vinay Prasad

Trends Cancer· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transcriptional profiling identifies an androgen receptor activity-low, stemness program associated with enzalutamide resistance.
Joshi J Alumkal, Duanchen Sun, Eric Lu, Tomasz M Beer, George V Thomas, Jeremy Cetnar

Proc Natl Acad Sci U S A· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Impact of Smoking and TP53 Mutations in Lung Adenocarcinoma Patients with Targetable Mutations-The Lung Cancer Mutation Consortium (LCMC2).
Dara L Aisner, Lynette M Sholl, Lynne D Berry, Michael R Rossi, Heidi Chen, Jeremy Cetnar

Clin Cancer Res· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Time from US Food and Drug Administration approval to publication of data for cancer drugs: a comparison of first and subsequent approvals.
Austin Lammers, Ruibin Wang, Jeremy Cetnar, Vinay Prasad

Blood Cancer J· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is it time to convert the frequency of radiotherapy in small-cell lung cancer?
Timur Mitin, Matthew Farrell, John Holland, Jeremy Cetnar, Charles R Thomas

Lancet Oncol· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune Checkpoint Inhibitors in Organ Transplant Patients.
Adam S Kittai, Hayden Oldham, Jeremy Cetnar, Matthew Taylor

J Immunother· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular Testing in Patients With Castration-Resistant Prostate Cancer and Its Impact on Clinical Decision Making.
Derrick L Tao, Shawna Bailey, Tomasz M Beer, Erik Foss, Brooke Beckett, Jeremy P Cetnar

JCO Precis Oncol· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of the American Society of Clinical Oncology's Conflict of Interest Policy on Information Overload.
Aaron Boothby, Ruibin Wang, Jeremy Cetnar, Vinay Prasad

JAMA Oncol· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early evidence of anti-PD-1 activity in enzalutamide-resistant prostate cancer.
Julie N Graff, Joshi J Alumkal, Charles G Drake, George V Thomas, William L Redmond, Jeremy P Cetnar

Oncotarget· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alectinib in ALK-positive, crizotinib-resistant, non-small-cell lung cancer: a single-group, multicentre, phase 2 trial.
Alice T Shaw, Leena Gandhi, Shirish Gadgeel, Gregory J Riely, Jeremy Cetnar

Lancet Oncol· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antioxidant micronutrients and the risk of renal cell carcinoma in the Women's Health Initiative cohort.
Won Jin Ho, Michael S Simon, Vedat O Yildiz, James M Shikany, Ikuko Kato, Jeremy P Cetnar

Cancer· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting DNA repair with combination veliparib (ABT-888) and temozolomide in patients with metastatic castration-resistant prostate cancer.
Maha Hussain, Michael A Carducci, Susan Slovin, Jeremy Cetnar, Jiang Qian

Invest New Drugs· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Personalizing prostate cancer therapy: the way forward.
Jeremy P Cetnar, Tomasz M Beer

Drug Discov Today· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NLR is predictive of upstaging at the time of radical cystectomy for patients with urothelial carcinoma of the bladder.
Aaron Potretzke, Luke Hillman, Kelvin Wong, Fangfang Shi, Ryan Brower, Jeremy P Cetnar

Urol Oncol· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Menstrual and reproductive factors and exogenous hormone use and risk of transitional cell bladder cancer in postmenopausal women.
Geoffrey C Kabat, Mimi Y Kim, Juhua Luo, Lifang Hou, Jeremy Cetnar

Eur J Cancer Prev· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis